A blood based biomarker identifying early Alzheimer Disease's pathology

Projektinformationen

VERDAD

ID Finanzhilfevereinbarung: 849834

DOI 10.3030/849834

Projekt abgeschlossen

EK-Unterschriftsdatum 24 Mai 2019

Startdatum 1 Juni 2019

Enddatum 30 November 2021

Finanziert unter

• INDUSTRIAL LEADERSHIP - Innovation In SMEs

Gesamtkosten € 3 365 416,25

EU-Beitrag € 2 355 791,00

Koordiniert durch

PRE DIAGNOSTICS AS
Norway

Leistungen

Demonstrators, pilots, prototypes (1)

Direct monocyte lysis and Aβ peptides recovery protocol

Websites, patent fillings, videos etc. (3)

Project website
Final project report

Final project report1PreDDECPUM30

Fully characterized mid domain beta Amyloid peptide mapping

Documents, reports (6)

Final protocol for large scale deployment of a fully automated method for Aβ peptides recovery from blood monocytes
Ethical approvals for the planned testing activities
Performance report from the in-vitro reference solutions tests
Societal demo activities report
CE-label documentation

CElabel documentation

Final automated immunoassay protocol

Open Research Data Pilot (1)

Performance report from the clinical blood samples

Rechte des geistigen Eigentums

Patent (2)

METHODS AND COMPOSITIONS FOR MONITORING PHAGOCYTIC ACTIVITY

Antrags-/Publikationsnummer: 11 805939
Datum: 2011-11-28

DIAGNOSTIC METHOD

Antrags-/Publikationsnummer: 09 709860
Datum: 2009-02-13